Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process

Javelot, Hervé; Dizet, Sophie; Straczek, Céline; Langrée, B.; Michel, Bruno; Haffen, Emmanuel; Bertschy, Gilles

doi:10.1016/j.therap.2020.12.011

Cited by 3 publications

(12 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, simplistic categorical diagnoses are abundantly used in contemporary psychiatric practice and have contributed to pharmacotherapy choices dictated by guidelines/algorithms [4,68]. Therefore, this decline in clinical curiosity in favour of a more standardized approach is potentially associated with impoverishing clinicians' knowledge of the pharmacological tools available [4,68].…”

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

“…For several years now, we have created in France a local skills network specializing in psychopharmacology [4,69]. Recent data bear witness to the fact that this network of expertise, involving both psychiatric pharmacists and psychiatrists, receives a large and growing number of requests, with a high level of satisfaction expressed by the doctors requesting it [4]. This system is also proving effective in terms of publications and in particular for formalizing professional recommendations [4].…”

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

“…Clinical Pharmacy is generally considered to have originated in the USA in the 1960s, while the supervising associations such as the American College of Clinical Pharmacy (ACCP) and the European Society of Clinical Pharmacy (ESCP) were created in 1979 [1][2][3]. English speaking countries, and the USA in particular, continue to serve as a benchmark in advancing clinical pharmacy [4]. One of the strongest axes of clinical pharmacy in English speaking countries is based on its specialization and the vision for the future expressed by the ACCP is that "most clinical pharmacy practitioners will be board certified specialists" [5].…”

Section: Introductionmentioning

confidence: 99%

“…The American Pharmaceutical Association created the Board of Pharmaceutical Specialties (BPS) in 1976 in order to create certification to qualified pharmacists, notably in pharmacotherapy (since 1988) and psychiatric pharmacy (since 1992) [5]. Interestingly, it appears that the pharmacist's qualification as a "drug specialist" may be called into question in the context of the practice of clinical pharmacy in some non-English-speaking countries [4]. The doctor of pharmacy degree (PharmD) may not be sufficient on its own, and may even require a "board-certified pharmacotherapy specialization".…”

Section: Introductionmentioning

confidence: 99%

“…While recent publications continue to demonstrate the interest and scalability of clinical pharmacy in psychiatry [4,[8][9][10], its deployment continues to be held back for various reasons [3,4,11,12].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

et al. 2021

Self Cite

View full text Add to dashboard Cite

Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered. In the field of mental health, psychiatric pharmacists are increasingly involved in medication reconciliation and therapeutic patient education (or psychoeducation) to improve medication management and enhance medication adherence, respectively. However, psychiatric pharmacists must now assume a growing role in team-based models of care and engage in shared expertise in psychopharmacology in order to truly invest in therapeutic optimization of psychotropics. The increased skills in psychopharmacology and expertise in psychotherapeutic drug monitoring can contribute to future strengthening of the partnership between psychiatrists and psychiatric pharmacists. We propose a narrative review of the literature in order to show the relevance of a clinical pharmacist specializing in psychiatry. With this in mind, herein we will address: (i) briefly, the areas considered the basis of the deployment of clinical pharmacy in mental health, with medication reconciliation, therapeutic education of the patient, as well as the growing involvement of clinical pharmacists in the multidisciplinary reflection on pharmacotherapeutic decisions; (ii) in more depth, we present data concerning the use of therapeutic drug monitoring and shared expertise in psychopharmacology between psychiatric pharmacists and psychiatrists. These last two points are currently in full development in France through the deployment of Resource and Expertise Centers in PsychoPharmacology (CREPP in French).

show abstract

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

La psychopharmacologie au service de la santé mentale : bilan du premier centre de ressources et d’expertise en psychopharmacologie (CREPP) en Bourgogne-Franche-Comté

Marceau¹,

Varnier²,

Dizet³

2023

Le Pharmacien Clinicien

View full text Add to dashboard Cite

Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis

Hirata¹,

Hanaoka²,

Rokutanda³

et al. 2023

J. pharm. pharm. sci.

View full text Add to dashboard Cite

Purpose: To investigate the value-to-value relationships, relationship between values and patient background, continuation rate of treatment after shared decision-making (SDM), and disease status in order to clarify the values involved in drug therapy decisions for patients with rheumatic disease.Methods: We investigated patient values (efficacy of drug therapy [effectiveness], safety, economics, daily life, and other) and the continuance rate and disease status of treatment after 6 months in 94 patients with rheumatic disease aged ≥18 years who made decisions with pharmacists and physicians in the pharmacy outpatient clinic between September 2019 and April 2021. Multiple correspondence and K-means cluster analyses were performed to show the relationship between values and basic patient information.Results: Among the selected patients, 87% and 47% selected effectiveness for multiple selections and single selection, respectively. Effectiveness was at the center of the graph; three clusters containing other values were placed around it. History of allergy or side effects caused by biologics or Janus kinase inhibitors were in the safety cluster. The non-usage history of biologics or Janus kinase inhibitors was in the economic cluster.Conclusion: Effectiveness was the most important factor for patients with rheumatic disease; the values that patients consider important may shift from effectiveness to other values based on each patient’s subjective experience with the treatment and/or the stage of life in which they were treated. It is important to positively link patient values and information about the treatment plan in shared decision-making while establishing rapport with the patient.

show abstract

Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process

Cited by 3 publications

References 41 publications

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

La psychopharmacologie au service de la santé mentale : bilan du premier centre de ressources et d’expertise en psychopharmacologie (CREPP) en Bourgogne-Franche-Comté

Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis

Contact Info

Product

Resources

About